{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:50:12Z","timestamp":1769723412108,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.radonc.2017.12.025","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T23:29:51Z","timestamp":1524698991000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Two decades of high dose rate brachytherapy with external beam radiotherapy for prostate cancer"],"prefix":"10.1016","volume":"127","author":[{"given":"Lennart","family":"\u00c5str\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Grusell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Sandin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingela","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.12.025_b0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.12.025_b0010","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group\/american college of radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2013.09.026","article-title":"Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival","volume":"110","author":"Heemsbergen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(97)00121-7","article-title":"Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma","volume":"44","author":"Borghede","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ijrobp.2003.08.003","article-title":"Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer","volume":"58","author":"Galalae","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.12.025_b0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2004.10.014","article-title":"Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer","volume":"74","author":"Astrom","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brachy.2012.05.003","article-title":"Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer","volume":"12","author":"Kotecha","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2017.12.025_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brachy.2013.11.002","article-title":"The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer \u2013 a benchmark for high-tech external beam radiotherapy alone?","volume":"13","author":"Galalae","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2017.12.025_b0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0167-8140(89)90089-3","article-title":"The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships","volume":"15","author":"Turesson","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","article-title":"Prostate cancer, version 1.2016","volume":"14","author":"Mohler","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radonc.2017.12.025_b0060","doi-asserted-by":"crossref","first-page":"654861","DOI":"10.1155\/2012\/654861","article-title":"Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer","volume":"2012","author":"Johansson","year":"2012","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.radonc.2017.12.025_b0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.12.025_b0070","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"key":"10.1016\/j.radonc.2017.12.025_b0075","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ijrobp.2011.10.055","article-title":"High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naive low- and intermediate-risk prostate cancer: a 7-year experience","volume":"83","author":"Aluwini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.12.025_b0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brachy.2013.05.004","article-title":"Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients","volume":"13","author":"Marina","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2017.12.025_b0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bju.13659","article-title":"Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years","volume":"120","author":"Yaxley","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2017.12.025_b0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijrobp.2009.10.035","article-title":"Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy","volume":"79","author":"Martinez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.12.025_b0095","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2214\/AJR.11.8351","article-title":"Whole-body diffusion-weighted MRI compared with (18)F-NaF PET\/CT for detection of bone metastases in patients with high-risk prostate carcinoma","volume":"199","author":"Mosavi","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.radonc.2017.12.025_b0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.semnuclmed.2016.07.003","article-title":"(18)F-NaF-PET\/CT and (99m)Tc-MDP bone scintigraphy in the detection of bone metastases in prostate cancer","volume":"46","author":"Langsteger","year":"2016","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.radonc.2017.12.025_b0105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.prro.2017.03.002","article-title":"Patterns of lymph node positivity on 11C-acetate PET imaging in correlation to the RTOG pelvic radiation field for prostate cancer","volume":"7","author":"McClinton","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0110","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1470-2045(15)70045-8","article-title":"High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01\/05 GICOR): a randomised, controlled, phase 3 trial","volume":"16","author":"Zapatero","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2012.05.007","article-title":"Late gastrointestinal and urogenital side-effects after radiotherapy \u2013 incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer","volume":"104","author":"Schmid","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0125","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0360-3016(03)00772-7","article-title":"Hazards of dose escalation in prostate cancer radiotherapy","volume":"57","author":"Kuban","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.12.025_b0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brachy.2008.03.003","article-title":"Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer","volume":"7","author":"Tharp","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2017.12.025_b0135","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/j.ijrobp.2011.11.040","article-title":"Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate","volume":"82","author":"Lawton","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.12.025_b0140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.12.025_b0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brachy.2012.03.004","article-title":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors","volume":"12","author":"Hindson","year":"2013","journal-title":"Brachytherapy"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017327809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017327809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T02:22:38Z","timestamp":1538619758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017327809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0167814017327809"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.12.025","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two decades of high dose rate brachytherapy with external beam radiotherapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}